412
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Synthetic pathway for a new series of liquid crystal 2,6-disubstituted imidazo[2,1-b][1,3,4]thiadiazole

, , , &
Pages 570-580 | Received 13 Jan 2013, Accepted 17 Feb 2013, Published online: 11 Mar 2013
 

Abstract

Herein, the synthesis of a novel series of liquid crystals 2,6-disubstituted imidazo[2,1-b]-1,3,4-thiadiazoles derivate is reported. These fused heterocyclic compounds were prepared through the cyclodehydration between 5-substituted-1,3,4-thiadiazole-2-amino derivatives and α-bromo aryl ketones. The derivates of 2-amino-thiadiazole were obtained from the condensation reaction between thiosemicarbazide and aryl/alkyl nitriles with good yields (60–83%). The α-bromination of aryl ketones was carried out using NBS as the source of electrophilic bromine, also with good yields (52–85%). For the final compounds, the liquid crystal behaviour was shown to be dependent on the number of chains. Mesomorphism was not observed for compounds without aliphatic chains, with more than two aliphatic chains or when the aliphatic chains are methoxy groups.

Acknowledgements

The authors are grateful to the following institutions for financial support: CNPq, CAPES/PNPD, INCT-cat, PRONEX/FAPESC and INCT/INEO. The X-ray diffraction experiments were performed at the Laboratório de Difração de Raios-X (LDRX-DF/UFSC).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.